PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $154,000 | -11.5% | 30,442 | +7.9% | 0.00% | 0.0% |
Q2 2019 | $174,000 | +30.8% | 28,214 | -1.7% | 0.00% | 0.0% |
Q1 2019 | $133,000 | +12.7% | 28,704 | +2.5% | 0.00% | 0.0% |
Q4 2018 | $118,000 | -34.4% | 28,010 | -2.6% | 0.00% | 0.0% |
Q3 2018 | $180,000 | -17.1% | 28,768 | +6.8% | 0.00% | 0.0% |
Q2 2018 | $217,000 | +30.7% | 26,937 | +20.9% | 0.00% | 0.0% |
Q1 2018 | $166,000 | +27.7% | 22,285 | +2.2% | 0.00% | 0.0% |
Q4 2017 | $130,000 | -8.5% | 21,802 | +13.1% | 0.00% | 0.0% |
Q3 2017 | $142,000 | +34.0% | 19,277 | +23.6% | 0.00% | 0.0% |
Q2 2017 | $106,000 | -23.2% | 15,599 | +7.0% | 0.00% | 0.0% |
Q1 2017 | $138,000 | – | 14,572 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|